Aetna backs Gilead's hepatitis C treatment and gets discount
January 16, 2015 at 14:34 PM EST
Jan 16 (Reuters) - Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.